FDA issues warning to antidepressant users
The Public Health Advisory issued by the FDA is designed to update patients and healthcare providers with the latest information on antidepressant use. The FDA is taking the
US-based biotechnology company Superluminal Medicines has completed a $60m Series B financing round to support its research into therapies for rare genetic forms of obesity and hypothalamic obesity.